Evaluation of the Khorana Predictive Thrombotic Risk and Thromboprophylaxis Score in Cancer Patients in a Third Level Hospital

INTRODUCTION: Current clinical guidelines do not recommend the routine use of thromboprophylaxis in cancer primary unselected patients. Identifying cancer patients who could be beneficiaries of thrombotic prophylaxis is a real challenge. We aimed to analyse the application of Khorana score in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bermejo, Lara Almudena Fernández, Esteban, José Javier Jareño, Díez, Javier de Miguel, Zabaleta, Irene Milagros Domínguez, Hernández, Carmen González, Rivas, María Pilar Ochoa, Ortega, Carlos Gutiérrez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369566/
https://www.ncbi.nlm.nih.gov/pubmed/37497323
http://dx.doi.org/10.1016/j.opresp.2022.100170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369566/
https://www.ncbi.nlm.nih.gov/pubmed/37497323
http://dx.doi.org/10.1016/j.opresp.2022.100170

Ejemplares similares